Agenda for September 2026 Immunisation Advisory Committee (IAC) meeting

Information on what the Immunisation Advisory Committee (IAC) will be considering at its upcoming meeting in September 2026.

The Committee will discuss the potential approach to an RSV immunisation programme in New Zealand.

Recombinant zoster vaccine (Shingrix) for immunocompromised people at increased risk of shingles

The Committee will discuss widening access to the recombinant zoster vaccine for immunocompromised people who are at increased risk of shingles and its complications. The Committee previously considered this topic at their March 2024 Immunisation Advisory Committee meeting(external link) and their June 2025 Immunisation Advisory Committee(external link). Further advice will be sought to confirm the eligibility criteria.

Human Papillomavirus 9-valent vaccine (Gardasil 9) widened access

The Committee will discuss an application to widen access for the Human Papillomavirus 9-valent (HPV) vaccine for people living with HIV who are aged 9 – 45 years.